Treace Medical Concepts Inc Cash Flow Reinvestment Rate

Latest as of March 2026: 1.08x

Treace Medical Concepts Inc cash flow reinvestment rate. Treace Medical Concepts Inc (TMCI) has a Cash Flow Reinvestment Rate of 1.08x as of March 2026, reinvesting $7.82 Million (capex $3.06 Million plus investments $-4.75 Million) from operating cash flow of $7.23 Million. See how financially flexible is Treace Medical Concepts Inc to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.08x
(Capex + Investments) / Operating CF

Total Reinvested

$7.82 Million
Capex + Investments

Operating Cash Flow

$7.23 Million
USD

Capital Expenditures

$3.06 Million
USD

Treace Medical Concepts Inc Cash Flow Reinvestment Rate by Year (None–None)

Treace Medical Concepts Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Treace Medical Concepts Inc. For the full cash flow conversion analysis, see TMCI cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow